As competition in the pharmaceutical market continues to grow, effective business development strategies become critical to maintain momentum and improve global market share for the leading pharma companies. More
With the current round of European enlargement is in its final phase this article discusses the implications for parallel imports from the accession countries. More
Recently enacted changes to pharmaceutical law in Japan provide significant opportunities for non-Japanese companies to increase their market presence in the country and provide manufacturing services to its pharmaceutical industry More
You are a senior business development manager of a biopharmaceutical company and you are seeking board approval for the acquisition of a drug candidate that has been developed in an EU Member State. More
Based on over 500 hundred hours of research with the industry, the BioBusiness agenda has been carefully refined to ensure you meet and exceed your networking goals. More
Displaying 1..10 of 83 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
